Brightside Health Raises Strategic Series C, Welcomes Trip Hofer to Board of Directors
Telemental health company Brightside Health today announced a strategic Series C raise led by S32, as well as the appointment of industry titan Trip Hofer to the Board of Directors to advise on go-to-market strategy and execution.
- Telemental health company Brightside Health today announced a strategic Series C raise led by S32, as well as the appointment of industry titan Trip Hofer to the Board of Directors to advise on go-to-market strategy and execution.
- “I’m honored to be joining Brightside Health’s Board of Directors as the company reaches this impressive milestone,” said Trip Hofer, Brightside Health board member and former CEO of Optum Behavioral Health Solutions.
- In fact, Brightside Health recently announced an expansion with payer partners including CareOregon, Blue Cross and Blue Shield of Texas, and Centene.
- “We’re thrilled to announce this raise and simultaneously welcome Trip, an incredible industry thought leader, to help propel Brightside Health into the next phase of our growth,” said Brad Kittredge, Co-Founder and CEO of Brightside Health.